Your session is about to expire
← Back to Search
tDCS for Post-Stroke Fatigue
Study Summary
This trial will investigate whether transcranial direct current stimulation (tDCS) can help improve fatigue and inflammation after a stroke.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- My gender or race does not limit my participation.It has been over 6 months since my stroke.I am between 35 and 80 years old.I have had strokes in both sides of my brain.I have a diagnosed neurological condition like MS, Parkinson's, or dementia.I have very high blood pressure.I have been feeling tired for the last 6 months.I don't have metal implants, a seizure history, or surgical clips that prevent MRI or TMS.I have had a stroke or lesion in my cerebellum or brainstem.I can walk 10 meters by myself.You currently have depression and/or anxiety disorders.
- Group 1: Real
- Group 2: Sham
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are individuals still being sought to participate in this research?
"This clinical trial, initially posted on the 12th of July and updated as recently as the 25th, is actively searching for eligible participants. Clinicaltrials.gov has all relevant information available to interested parties."
Who meets the qualifications necessary to participate in this clinical trial?
"The researchers are seeking a cohort of 24 stroke survivors aged between 35 and 80 years old. Prerequisites for enrolment include: male or female, any ethnicity, post-stroke 6+ months prior to screening, presence of fatigue symptoms over the past half year, able to walk 10 meters unassisted."
Does this medical study accept participants who are 40 and above?
"This clinical study is searching for test subjects aged between 35 and 80."
What is the size of the participant pool for this clinical evaluation?
"Affirmative, the information on clinicaltrials.gov indicates that this trial is currently enrolling subjects. This research project was first available to prospective patients on July 12th 2022 and has been amended most recently on July 25th 2022. The 24 participants required must be sourced from only 1 medical facility."
Share this study with friends
Copy Link
Messenger